12. Armbruster D, Mueller A, Strobel A, Kirschbaum C, Lesch KP, et al. (2010) Influence of functional tryptophan hydroxylase 2 gene variation and sex on the startle response in children, young adults, and older adults. Biol Psychol 83: 214–221. 13. Goswami DB, May WL, Stockmeier CA, Austin MC (2010) Transcriptional expression of serotonergic regulators in laser-captured microdissected dorsal raphe neurons of subjects with major depressive disorder: sex-specific differences. J Neurochem 112: 397–409. 14. Celada P, Puig M, Amargos-Bosch M, Adell A, Artigas F (2004) The therapeutic role of 5-HT1A and 5-HT2A receptors in depression. J Psychiatry Neurosci 29: 252–265. 15. Drevets WC, Thase ME, Moses-Kolko EL, Price J, Frank E, et al. (2007) Serotonin-1A receptor imaging in recurrent depression: replication and literature review. Nucl Med Biol 34: 865–877. 16. Messa C, Colombo C, Moresco RM, Gobbo C, Galli L, et al. (2003) 5-HT(2A) receptor binding is reduced in drug-naive and unchanged in SSRI-responder depressed patients compared to healthy controls: a PET study. Psychopharma- cology (Berl) 167: 72–78. 17. Sargent PA, Kjaer KH, Bench CJ, Rabiner EA, Messa C, et al. (2000) Brain serotonin1A receptor binding measured by positron emission tomography with [11C]WAY-100635: effects of depression and antidepressant treatment. Arch Gen Psychiatry 57: 174–180. 18. Stockmeier CA, Shapiro LA, Dilley GE, Kolli TN, Friedman L, et al. (1998) Increase in serotonin-1A autoreceptors in the midbrain of suicide victims with major depression-postmortem evidence for decreased serotonin activity. J Neurosci 18: 7394–7401. 19. Yatham LN, Liddle PF, Shiah IS, Scarrow G, Lam RW, et al. (2000) Brain serotonin2 receptors in major depression: a positron emission tomography study. Arch Gen Psychiatry 57: 850–858. 20. Szewczyk B, Albert PR, Burns AM, Czesak M, Overholser JC, et al. (2009) Gender-specific decrease in NUDR and 5-HT1A receptor proteins in the prefrontal cortex of subjects with major depressive disorder. Int J Neuropsychopharmacol 12: 155–168. 21. Rossi DV, Burke TF, McCasland M, Hensler JG (2008) Serotonin-1A receptor function in the dorsal raphe nucleus following chronic administration of the selective serotonin reuptake inhibitor sertraline. J Neurochem 105: 1091–1099. 22. El Yacoubi M, Bouali S, Popa D, Naudon L, Leroux-Nicollet I, et al. (2003) Behavioral, neurochemical, and electrophysiological characterization of a genetic mouse model of depression. Proc Natl Acad Sci U S A 100: 6227–6232. 23. Overstreet DH, Commissaris RC, De La Garza R, 2nd, File SE, Knapp DJ, et al. (2003) Involvement of 5-HT1A receptors in animal tests of anxiety and depression: evidence from genetic models. Stress 6: 101–110. 24. Richardson-Jones JW, Craige CP, Guiard BP, Stephen A, Metzger KL, et al. (2010) 5-HT1A autoreceptor levels determine vulnerability to stress and response to antidepressants. Neuron 65: 40–52. 25. van Gaalen MM, Reul JH, Gesing A, Stenzel-Poore MP, Holsboer F, et al. (2002) Mice overexpressing CRH show reduced responsiveness in plasma corticosterone after a5-HT1A receptor challenge. Genes Brain Behav 1: 174–177. 26. Bauer A, Zilles K, Matusch A, Holzmann C, Riess O, et al. (2005) Regional and subtype selective changes of neurotransmitter receptor density in a rat transgenic for the Huntington’s disease mutation. J Neurochem 94: 639–650. 27. Pang TY, Du X, Zajac MS, Howard ML, Hannan AJ (2009) Altered serotonin receptor expression is associated with depression-related behavior in the R6/1 transgenic mouse model of Huntington’s disease. Hum Mol Genet 18: 753–766. 28. Yohrling IG, Jiang GC, DeJohn MM, Robertson DJ, Vrana KE, et al. (2002) Inhibition of tryptophan hydroxylase activity and decreased 5-HT1A receptor binding in a mouse model of Huntington’s disease. J Neurochem 82: 1416–1423. 29. Pouladi MA, Graham RK, Karasinska JM, Xie Y, Santos RD, et al. (2009) Prevention of depressive behaviour in the YAC128 mouse model of Huntington disease by mutation at residue 586 of huntingtin. Brain 132: 919–932. 30. Zajac MS, Pang TY, Wong N, Weinrich B, Leang LS, et al. (2009) Wheel running and environmental enrichment differentially modify exon-specific BDNF expression in the hippocampus of wild-type and pre-motor symptomatic male and female Huntington’s disease mice. Hippocampus. 31. Nithianantharajah J, Barkus C, Murphy M, Hannan AJ (2008) Gene- environment interactions modulating cognitive function and molecular corre- lates of synaptic plasticity in Huntington’s disease transgenic mice. Neurobiol Dis 29: 490–504. 32. Pang TY, Stam NC, Nithianantharajah J, Howard ML, Hannan AJ (2006) Differential effects of voluntary physical exercise on behavioral and brain- derived neurotrophic factor expression deficits in Huntington’s disease transgenic mice. Neuroscience 141: 569–584. 33. Harkin A, Houlihan DD, Kelly JP (2002) Reduction in preference for saccharin by repeated unpredictable stress in mice and its prevention by imipramine. J Psychopharmacol 16: 115–123. 34. Dulawa SC, Hen R (2005) Recent advances in animal models of chronic antidepressant effects: the novelty-induced hypophagia test. Neurosci Biobehav Rev 29: 771–783. 35. Bill DJ, Knight M, Forster EA, Fletcher A (1991) Direct evidence for an important species difference in the mechanism of 8-OH-DPAT-induced hypothermia. Br J Pharmacol 103: 1857–1864. 36. Bert B, Fink H, Hortnagl H, Veh RW, Davies B, et al. (2006) Mice over- expressing the 5-HT(1A) receptor in cortex and dentate gyrus display exaggerated locomotor and hypothermic response to 8-OH-DPAT. Behav Brain Res 167: 328–341. 37. Hedlund PB, Kelly L, Mazur C, Lovenberg T, Sutcliffe JG, et al. (2004) 8-OH- DPAT acts on both 5-HT1A and 5-HT7 receptors to induce hypothermia in rodents. Eur J Pharmacol 487: 125–132. 38. Bai F, Li X, Clay M, Lindstrom T, Skolnick P (2001) Intra- and interstrain differences in models of ‘‘behavioral despair’’. Pharmacol Biochem Behav 70: 187–192. 39. Renoir T, Paizanis E, Yacoubi ME, Saurini F, Hanoun N, et al. (2008) Differential long-term effects of MDMA on the serotoninergic system and hippocampal cell proliferation in 5-HTT knock-out vs. wild-type mice. Int J Neuropsychopharmacol 11: 1149–1162. 40. Dalla C, Pitychoutis PM, Kokras N, Papadopoulou-Daifoti Z (2009) Sex Differences in Animal Models of Depression and Antidepressant Response. Basic Clin Pharmacol Toxicol. 41. Sun Y, Zupan B, Raaka BM, Toth M, Gershengorn MC (2009) TRH-receptor- type-2-deficient mice are euthyroid and exhibit increased depression and reduced anxiety phenotypes. Neuropsychopharmacology 34: 1601–1608. 42. Bode FJ, Stephan M, Suhling H, Pabst R, Straub RH, et al. (2008) Sex differences in a transgenic rat model of Huntington’s disease: decreased 17beta- estradiol levels correlate with reduced numbers of DARPP32+ neurons in males. Hum Mol Genet 17: 2595–2609. 43. Dorner JL, Miller BR, Barton SJ, Brock TJ, Rebec GV (2007) Sex differences in behavior and striatal ascorbate release in the 140 CAG knock-in mouse model of Huntington’s disease. Behav Brain Res 178: 90–97. 44. Wood NI, Carta V, Milde S, Skillings EA, McAllister CJ, et al. (2010) Responses to environmental enrichment differ with sex and genotype in a transgenic mouse model of Huntington’s disease. PLoS One 5: e9077. 45. Kornstein SG, Schatzberg AF, Thase ME, Yonkers KA, McCullough JP, et al. (2000) Gender differences in treatment response to sertraline versus imipramine in chronic depression. Am J Psychiatry 157: 1445–1452. 46. Renard CE, Fiocco AJ, Clenet F, Hascoet M, Bourin M (2001) Is dopamine implicated in the antidepressant-like effects of selective serotonin reuptake inhibitors in the mouse forced swimming test? Psychopharmacology (Berl) 159: 42–50. 47. Rogoz Z, Skuza G (2006) Mechanism of synergistic action following co- treatment with pramipexole and fluoxetine or sertraline in the forced swimming test in rats. Pharmacol Rep 58: 493–500. 48. Sarkisyan G, Roberts AJ, Hedlund PB (2010) The 5-HT(7) receptor as a mediator and modulator of antidepressant-like behavior. Behav Brain Res 209: 99–108. 49. Dawson LA, Nguyen HQ, Smith DL, Schechter LE (2002) Effect of chronic fluoxetine and WAY-100635 treatment on serotonergic neurotransmission in the frontal cortex. J Psychopharmacol 16: 145–152. 50. Bouali S, Evrard A, Chastanet M, Lesch KP, Hamon M, et al. (2003) Sex hormone-dependent desensitization of 5-HT1A autoreceptors in knockout mice deficient in the 5-HT transporter. Eur J Neurosci 18: 2203–2212. 51. Li Q, Wichems C, Heils A, Lesch KP, Murphy DL (2000) Reduction in the density and expression, but not G-protein coupling, of serotonin receptors (5- HT1A) in 5-HT transporter knock-out mice: gender and brain region differences. J Neurosci 20: 7888–7895. 52. Nakano Y, Matsuda T, Takuma K, Yoshikawa T, Baba A (1992) Sex difference for tolerance of 5-HT1A receptor-mediated temperature and corticosterone responses in mice. Eur J Pharmacol 219: 339–341. 53. Reynolds GP, Dalton CF, Tillery CL, Mangiarini L, Davies SW, et al. (1999) Brain neurotransmitter deficits in mice transgenic for the Huntington’s disease mutation. J Neurochem 72: 1773–1776. 54. Overstreet DH (2002) Behavioral characteristics of rat lines selected for differential hypothermic responses to cholinergic or serotonergic agonists. Behav Genet 32: 335–348. 55. Lira A, Zhou M, Castanon N, Ansorge MS, Gordon JA, et al. (2003) Altered depression-related behaviors and functional changes in the dorsal raphe nucleus of serotonin transporter-deficient mice. Biol Psychiatry 54: 960–971. 56. Olivier JD, Van Der Hart MG, Van Swelm RP, Dederen PJ, Homberg JR, et al. (2008) A study in male and female 5-HT transporter knockout rats: an animal model for anxiety and depression disorders. Neuroscience 152: 573–584. 57. Kinney GG, Vogel GW, Feng P (1997) Decreased dorsal raphe nucleus neuronal activity in adult chloral hydrate anesthetized rats following neonatal clomipra- mine treatment: implications for endogenous depression. Brain Res 756: 68–75. 58. Frey BN, Rosa-Neto P, Lubarsky S, Diksic M (2008) Correlation between serotonin synthesis and 5-HT1A receptor binding in the living human brain: a combined alpha-[11C]MT and [18F]MPPF positron emission tomography study. Neuroimage 42: 850–857. 59. Miller JM, Brennan KG, Ogden TR, Oquendo MA, Sullivan GM, et al. (2009) Elevated serotonin 1A binding in remitted major depressive disorder: evidence for a trait biological abnormality. Neuropsychopharmacology 34: 2275–2284. 60. Bhagwagar Z, Rabiner EA, Sargent PA, Grasby PM, Cowen PJ (2004) Persistent reduction in brain serotonin1A receptor binding in recovered depressed men measured by positron emission tomography with [11C]WAY-100635. Mol Psychiatry 9: 386–392. 61. Mnie-Filali O, Lambas-Senas L, Zimmer L, Haddjeri N (2007) 5-HT7 receptor antagonists as a new class of antidepressants. Drug News Perspect 20: 613–618. 62. Frey BN, Skelin I, Sakai Y, Nishikawa M, Diksic M (2010) Gender differences in alpha-[(11)C]MTrp brain trapping, an index of serotonin synthesis, in PLoS ONE | www.plosone.org 10 July 2011 | Volume 6 | Issue 7 | e22133